TORONTO, Nov. 22, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (“Canada House” or the “Company”) (CSE:CHV) is
pleased to announce the immediate granting of 4,300,000 stock options to senior employees at an exercise price of $0.17 and with a
term of 5-years. The grant was made in accordance with the Company’s stock option plan and the policies of the Canadian Securities
Exchange.
Canada House Wellness Group Inc.
Canada House is an experienced, integrated medical cannabis company providing patient-specific cannabinoid therapy products and
services through its clinics and licensed producer. Canada House is the parent company of Canada House Clinics Inc., Knalysis
Technologies and Abba Medix Corp. For more information, please visit www.canadahouse.ca or www.sedar.com.
For further information, please contact:
Boom Capital Markets
Steve Low
647-620-5101
steve@boomcapitalmarkets.com
Canada House Wellness Group Inc.
Chris Churchill-Smith, CEO
514-313-0102
chris.smith@canadahouse.ca
Cautionary Statement Regarding Forward Looking Information. This press release contains forward-looking
statements, including statements that relate to, among other things, the Company’s clinic, production and technology businesses,
its future plans, the Company’s markets, objectives, goals, strategies, intentions, beliefs, expectations and estimates, and can
generally be identified by the use of words such as “may”, “will”, “could”, “should”, “would”, “likely”, “possible”, “expect”,
“intend”, “estimate”, “anticipate”, “believe”, “plan”, “objective” and “continue” (or the negative thereof) and words and
expressions of similar import. Although the Company believes that the expectations reflected in such forward-looking statements are
reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed on
such statements.
Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ
materially from those expressed or implied in such statements. Material assumptions used to develop forward-looking information in
this news release include, among other things, the regulations related to cannabis use under the Access to Cannabis for Medical
Purposes Regulations and the act respecting cannabis and to amend the Controlled Drugs
and Substances Act, the Criminal Code and other Acts, passed by the Canadian Federal government, making cannabis legal for
recreational use by October 17, 2018; Company liquidity and capital resources, including the availability of additional capital
resources to fund its activities; level of competition; the ability to adapt products and services to the changing market; the
ability to attract and retain key executives; and the ability to execute strategic plans. Additional information about material
factors that could cause actual results to differ materially from expectations and about material factors or assumptions applied in
making forward-looking statements may be found in the Company’s most recent annual and interim Management’s Discussion and Analysis
under “Risk and Uncertainties” as well as in other public disclosure documents filed with Canadian securities regulatory
authorities. The Company does not undertake any obligation to update publicly or to revise any of the forward-looking statements
contained in this document, whether as a result of new information, future events or otherwise, except as required by law.
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility
for the adequacy or accuracy of this release.
